Overview
Roberto Menicagli practices practicing medicine in Milan, Italy.
His clinical expertise encompasses Common Cold, Laryngeal Cancer, Throat Cancer, and Dry Mouth.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Roberto Menicagli
Is Roberto Menicagli a top-rated expert for Common Cold?
MediFind is an objective health platform that identifies experts based on real-world data. Roberto Menicagli is classified as an Experienced expert for Common Cold, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Roberto Menicagli participate in research or clinical trials?
Yes. Roberto Menicagli has published 11 articles and abstracts on conditions like Common Cold. You can view a list of Roberto Menicagli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Common ColdMr. Menicagli isExperienced. Learn about Common Cold.
- Dry MouthMr. Menicagli isExperienced. Learn about Dry Mouth.
- Laryngeal CancerMr. Menicagli isExperienced. Learn about Laryngeal Cancer.
- Throat CancerMr. Menicagli isExperienced. Learn about Throat Cancer.